MITI (Mitesco) 3-Year EPS without NRI Growth Rate: 46.30% (As of Mar. 2026) — 312% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Mitesco 3-Year EPS without NRI Growth Rate?

Mitesco MITI -5.53% 3-Year EPS without NRI Growth Rate is 46.30% as of Mar. 2026, which is 312% above its 10-year median of 11.25. The stock has 5 warning signs investors should review. Among 508 Healthcare Providers & Services companies, Mitesco ranks better than 86.22% on this metric.

Mitesco's EPS without NRI for the three months ended in Mar. 2026 was $-0.05.

During the past 3 years, the average EPS without NRI Growth Rate was 46.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 38.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 25.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Mitesco was 82.60% per year. The lowest was -56.90% per year. And the median was 11.25% per year.


Mitesco  (OTCPK:MITI) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Mitesco 3-Year EPS without NRI Growth Rate Related Terms


MITI vs DOGP, ESSI, ZCMD: 3-Year EPS without NRI Growth Rate Comparison

For the Health Information Services subindustry, Mitesco's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mitesco 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mitesco's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Mitesco's 3-Year EPS without NRI Growth Rate falls into.



Mitesco 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

What does a 3-Year EPS without NRI Growth Rate of 46.30% mean?
Mitesco (MITI) has a 3-Year EPS without NRI Growth Rate of 46.30% as of Mar. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Mitesco and its competitors. This is 312% above median its historical median of 11.25. According to the industry distribution chart, Mitesco ranks #70 out of 508 companies in the Healthcare Providers & Services industry, placing it in the top 13.8%.
Is Mitesco's 3-Year EPS without NRI Growth Rate too high?
Mitesco's current 3-Year EPS without NRI Growth Rate of 46.30% is 312% above median its 10-year median of 11.25. The Healthcare Providers & Services industry median 3-Year EPS without NRI Growth Rate is 11.30. Mitesco's value of 46.30% is 309.7% above this industry median. Based on the distribution chart, Mitesco ranks #70 out of 508 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Mitesco's 3-Year EPS without NRI Growth Rate compare to DOGP and ESSI?
According to the Healthcare Providers & Services industry distribution chart, Mitesco ranks #70 out of 508 companies for 3-Year EPS without NRI Growth Rate. This places Mitesco in the top 14% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 11.30. Mitesco's value of 46.30% is 309.7% above this benchmark. While the company's 10-year median is 11.25 vs. the industry median of 11.30, Mitesco has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 11.30, based on 508 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mitesco's current 3-Year EPS without NRI Growth Rate of 46.30% is 309.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Mitesco and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 11.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mitesco's current 3-Year EPS without NRI Growth Rate is 46.30%, which is 312% above median its own 10-year median of 11.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mitesco stock overvalued right now?
Mitesco (MITI) has a current 3-Year EPS without NRI Growth Rate of 46.30%. The current 3-Year EPS without NRI Growth Rate is 46.30%, which is 312% above median its 10-year median of 11.25 and 309.7% above the Healthcare Providers & Services industry median of 11.30. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Mitesco (MITI), the current 3-Year EPS without NRI Growth Rate is 46.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mitesco Business Description

Address 505 Beachland Boulevard, Suite 1377, Vero Beach, FL, USA, 32963
Mitesco Inc is a holding company focused on developing products, services, and technology solutions through its wholly owned subsidiaries. The company, through its subsidiaries, provides data center services, cloud computing, application hosting, and managed services offerings, pursues investment, acquisition, and internal development opportunities in cloud computing, data center applications, and artificial intelligence software solutions. The company is also developing AI-driven products, including Robo Agent, and evaluating additional cloud-based software opportunities. The firm principally earns revenue by providing generic data center services, which is aimed at hosting applications for a specific user, sometimes referred to as "managed services offerings" or MSO.